Diabetes y enfermedades metabólicas
![Foto de Diabetes y enfermedades metabólicas](/img/grupo.png)
![Foto de Universidad Austral de Chile](/img/noimage_org.png)
Universidad Austral de Chile
Valdivia, ChileUniversidad Austral de Chile-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Frontiers in Pharmacology, Vol. 13
2020
-
Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities
International Journal of Molecular Sciences, Vol. 21, Núm. 7
-
Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy
International Journal of Molecular Sciences, Vol. 21, Núm. 11
2018
-
Targeting inflammation in diabetic nephropathy: a tale of hope
Expert Opinion on Investigational Drugs, Vol. 27, Núm. 11, pp. 917-930
2010
-
Regulation of vascular and renal cells by common mediators in health and disease: Role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease
Cardiorenal Syndrome: Mechanisms, Risk and Treatment (Springer Milan), pp. 49-63
-
Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a TGF-β-independent process
PLoS ONE, Vol. 5, Núm. 11